EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity

Muriel Huss, Tanja Elger, Claudia Kunst, Johanna Loibl, Sabrina Krautbauer, Gerhard Liebisch iD, Arne Kandulski iD, Martina Müller iD, Hauke Christian Tews, Christa Buechler iD

International Journal of Molecular Sciences · 24.04.2025 · 26 (9) · 4034

DOI: 10.3390/ijms26094034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2025. Verfasst von Muriel Huss und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, Immunology, and Infectious Diseases, University Hospita…. Hauptthemen laut MEDLINE: Feces, Arachidonic Acid, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arachidonic acid levels are elevated in the colonic mucosa of patients with inflammatory bowel disease (IBD). Fecal metabolites are emerging as valuable diagnostic tools for IBD. This study aimed to investigate associations between 31 fecal fatty acids, including arachidonic acid, to identify potential correlations with disease severity. Among the 31 fatty acids analyzed in feces, dihomo-γ-linolenic acid, arachidonic acid, and adrenic acid were significantly increased in patients with IBD compared to controls. In contrast, levels of linoleic acid and γ-linolenic acid, the precursors of arachidonic acid, were similar between both groups. No significant differences in fatty acid levels were observed between patients with Crohn’s disease and ulcerative colitis. Arachidonic acid and adrenic acid levels positively correlated with fecal calprotectin, a clinically established marker of IBD severity, but showed no association with stool consistency or the Gastrointestinal Symptom Rating Scale. This suggests that these fatty acids are linked to disease severity rather than disease-related symptoms. Current IBD-specific medications had no significant impact on the fecal levels of any of the 31 fatty acids. In summary, this study demonstrates elevated fecal levels of dihomo-γ-linolenic acid, arachidonic acid, and adrenic acid in IBD patients. Normal levels of precursor fatty acids suggest that impaired downstream metabolism may contribute to the accumulation of these n-6 polyunsaturated fatty acids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesArachidonic AcidInflammatory Bowel DiseasesHumansMaleBiomarkersFemaleAdultMiddle AgedSeverity of Illness IndexLeukocyte L1 Antigen ComplexYoung Adult8,11,14-Eicosatrienoic AcidCase-Control StudiesFatty AcidsColitis, UlcerativeFatty Acids, Unsaturated

Stichwörter der Autor:innen

biomarkercalprotectinfatty acidsfecesinflammatory bowel diseasestool consistency

Substanzen

Arachidonic AcidBiomarkersLeukocyte L1 Antigen Complex8,11,14-Eicosatrienoic Acidadrenic acidFatty AcidsFatty Acids, Unsaturated

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, Immunology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany.

ORCID-Profile: Gerhard Liebisch, Arne Kandulski, Martina Müller, Christa Buechler

Zitieren

APA

Huss, M., Elger, T., Kunst, C., Loibl, J., Krautbauer, S., Liebisch, G., Kandulski, A., Müller, M., Tews, H. C., & Buechler, C. (2025). Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity. International Journal of Molecular Sciences, 26(9), 4034. https://doi.org/10.3390/ijms26094034

Vancouver

Huss M, Elger T, Kunst C, Loibl J, Krautbauer S, Liebisch G, et al. Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity. International Journal of Molecular Sciences. 2025;26(9):4034. doi:10.3390/ijms26094034

BibTeX
@article{Huss2025,
  author = {Huss, Muriel and Elger, Tanja and Kunst, Claudia and Loibl, Johanna and Krautbauer, Sabrina and Liebisch, Gerhard and Kandulski, Arne and Müller, Martina and Tews, Hauke Christian and Buechler, Christa},
  title = {Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease Severity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {4034},
  doi = {10.3390/ijms26094034}
}
Kostenlos starten →